✦ LIBER ✦

The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer

✍ Scribed by Rupert Bartsch; Brigitte Mlineritsch; Michael Gnant; Thomas Niernberger; Ursula Pluschnig; Richard Greil; Catharina Wenzel; Paul Sevelda; Josef Thaler; Margaretha Rudas; Michael Pober; Christoph C. Zielinski; Guenther G. Steger; on behalf of the Austrian Fulvestrant Registry

Publisher: Springer US
Year: 2008
Tongue: English
Weight: 236 KB
Volume: 115
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-008-0132-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective assessment of the endometriu

Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrant

✍ Leilani Morales; Patrick Neven; Dirk Timmerman; Hans Wildiers; Maja L. Konstanti 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 180 KB

Fulvestrant in heavily pre-treated patie

Fulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centre

✍ Chiara Catania; Gilda Ascione; Laura Adamoli; Tommaso De Pas; Marta Medici; Luci 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 173 KB

Fulvestrant (‘Faslodex’) in heavily pret

Fulvestrant (‘Faslodex’) in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programme

✍ Brigitte Mlineritsch; Oskar Psenak; Peter Mayer; Martin Moik; Konrad Namberger; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 300 KB

Results of a phase II study comparing th

Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)

✍ Kathleen I. Pritchard; Janusz Rolski; Zsuzsanna Papai; Louis Mauriac; Fatima Car 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 363 KB

Activity of fulvestrant versus exemestan

Activity of fulvestrant versus exemestane in advanced breast cancer patients with or without visceral metastases: data from the EFECT trial

✍ Louis Mauriac; Gilles Romieu; José Bines 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 235 KB

The potential risk of neoadjuvant chemot

The potential risk of neoadjuvant chemotherapy in breast cancer patients—results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)

✍ Susanne Taucher; Guenther G. Steger; Raimund Jakesz; Christoph Tausch; Viktor We 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 252 KB